Prior to Dr. Reddy’s, Vin held senior leadership roles at Amneal Pharmaceuticals, G&W Laboratories, GlaxoSmithKline, UCB ...

Chief Financial Officer Julie Brown noted, "Core operating margin improved to 29.2%, up 130 basis points year-on-year," driven by specialty medicines and supply chain efficiencies. GSK expects ...

Gemini Bioproducts, LLC ("GeminiBio"), a biopharma and advanced therapy raw materials supplier, and a portfolio company of ...

Developers celebrate gains for advances with radiopharmaceuticals while regulators and isotope suppliers work to keep up.

“We are very impressed with Syngene’s professionalism, commitment to scientific excellence, and ability to deliver high-quality work on time,” said Allan Wehnert, CEO & Founder of Orocidin. “This ...

GSK'227 targets B7-H3 ... benefiting from the positive mix from specialty medicines and the supply chain efficiencies. Despite incorporating £150 million charge to drive future supply chain ...

The molecule is also being tested in over 100 vaccine clinical trials. Rising QS-21 demand from the pharmaceutical industry ...

The cohort, which includes Thermo Fisher Scientific, Haleon, Gilead Sciences and GSK, is part of the Energize programme, a ...

Jeff Bezos also spoke at the forum, which was held just 50 miles west of Cape Canaveral, about his space company Blue Origin. He said the real reason he is interested in space travel… ...

GSK has pledged to 100% use of renewable across the company by 2025, and an 80% reduction in carbon emissions by 2030 en route to net zero across all its supply chain – including purchased goods ...

Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today announced a 10-year virtual power purchasing agreement (VPPA) with international renewable energy developer X-ELIO ...